封面
市場調查報告書
商品編碼
1373859

全球靜脈曲張治療市場 - 市場規模、佔有率、成長分析:按類型、最終用途 - 產業預測(2023-2030)

Global Varicose Veins Treatment Market Size, Share, Growth Analysis, By Type(Endovenous Ablation, and Surgical Ligation & Stripping), By End-use(Vein clinics, hospitals) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計2021年全球靜脈曲張治療市場規模為12.2億美元,2022年為13億美元。預計在預測期(2023-2030年),市場將以6.32%的年複合成長率擴張,到2030年將達到21.2億美元。

全球靜脈曲張治療市場近年來取得了顯著成長,預計未來將繼續擴大。靜脈曲張是一種常見的疾病,其特徵是靜脈腫脹和扭曲,主要發生在腿部。人口高齡化、久坐的生活方式、肥胖和遺傳因素等因素導致全球靜脈曲張盛行率不斷上升,推動了對有效治療方案的需求。市面上有多種治療方法,包括內源性雷射消融、硬化療法和射頻消融等微創手術。與傳統手術方法相比,這些手術具有減輕疼痛、加速恢復時間和最小化疤痕等優點。微創治療的日益普及正在推動靜脈曲張治療市場的成長。此外,技術和醫療設備的進步正在進一步改善治療結果和患者滿意度。超音波導引泡沫硬化療法和非熱消融等創新技術在有效治療靜脈曲張方面顯示出良好的效果。這些進步不僅擴大了可用的治療選擇,而且改善了患者的整體體驗。然而,儘管市場成長潛力巨大,但也存在一些挑戰。報銷問題和高昂的治療費用可能會限制某些患者獲得靜脈曲張治療。保險覆蓋範圍和報銷政策不足可能會造成經濟障礙,尤其是在新興經濟體。

關於靜脈曲張和可用治療方案的意識和教育的不斷提高正在促進市場的成長。公眾宣傳活動、患者教育活動以及透過各種管道普及資訊鼓勵靜脈曲張患者接受適當的治療。

積極的報銷政策,特別是在已開發國家,促進了患者獲得靜脈曲張治療。對硬化療法和靜脈消融等手術的保險範圍和報銷支持使這些治療方法變得更實惠和容易獲得,從而推動了市場成長。

該報告研究了全球靜脈曲張治療市場,並提供了市場概述,包括按類型、最終用途、地區和參與市場的公司概況分類的趨勢。

目錄

執行摘要

母市場分析

市場規模

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

關鍵市場洞察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 趨勢分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 頂級投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
  • 法規狀況
  • 波特分析

按類型分類的全球靜脈曲張治療市場

  • 市場概況
  • 靜脈消融
  • 手術結紮、剝離

全球靜脈曲張治療市場(依最終用途)

  • 市場概況
  • 靜脈診所
  • 醫院
  • 和門診治療設施。

全球靜脈曲張治療市場(按地區)

  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

競爭形勢

  • 主要企業簡介
    • Medtronic
    • AngioDynamics
    • Lumenis
    • Syneron Medical Ltd.
    • Biolitec AG
    • BTG International Ltd
    • Vascular Solutions, Inc.
    • Energist Group
    • Eufoton
    • Quanta System
    • Miravas
    • Vein Clinics of America
    • Alna-Medical System GmbH
    • Miravas SAS
    • Sciton, Inc.
    • Dornier MedTech GmbH
    • LSO Medical
    • Vascular Insights, LLC
    • WONTECH Co., Ltd.
    • LSO Medical SAS
簡介目錄
Product Code: SQMIG35E2025

Global Varicose Veins Treatment Market size was valued at USD 1.22 Billion in 2021 and is poised to grow from USD 1.3 Billion in 2022 to USD 2.12 Billion by 2030, at a CAGR of 6.32% during the forecast period (2023-2030).

The global varicose veins treatment market has experienced significant growth in recent years and is expected to continue expanding in the coming years. Varicose veins are a common medical condition characterized by swollen and twisted veins, primarily in the legs. Factors such as aging population, sedentary lifestyles, obesity, and hereditary factors contribute to the rising prevalence of varicose veins worldwide, driving the demand for effective treatment options. Several treatment modalities are available in the market, including minimally invasive procedures such as endogenous laser ablation, sclerotherapy, and radiofrequency ablation. These procedures offer advantages such as reduced pain, shorter recovery time, and minimal scarring compared to traditional surgical methods. The increasing adoption of minimally invasive treatments is fueling the growth of the varicose veins treatment market. Moreover, advancements in technology and medical devices have further improved treatment outcomes and patient satisfaction. Innovative techniques, such as ultrasound-guided foam sclerotherapy and non-thermal ablation, have shown promising results in effectively treating varicose veins. These advancements have not only expanded the treatment options available but also enhanced the overall patient experience. However, despite the market's growth potential, several challenges exist. Reimbursement issues and the high cost of treatment can limit the accessibility of varicose veins treatment for some patients. Inadequate insurance coverage and reimbursement policies may pose financial barriers, particularly in developing countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Varicose Veins Treatment Market Segmental Analysis

The global varicose veins treatment market is segmented on the basis of type, end-use, and region. By type, the market is segmented into Endovenous Ablation, and Surgical Ligation & Stripping. By end use, the market is segmented into vein clinics, hospitals, and ambulatory care units. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Varicose Veins Treatment Market Dynamics

Drivers of the Global Varicose Veins Treatment Market

Growing Awareness and Patient Education

Increased awareness and education regarding varicose veins and available treatment options have contributed to market growth. Public awareness campaigns, patient education initiatives, and information dissemination through various channels have encouraged individuals with varicose veins to seek appropriate treatment.

Favorable Reimbursement Policies

Positive reimbursement policies, particularly in developed countries, have facilitated access to varicose veins treatment for patients. Insurance coverage and reimbursement support for procedures like sclerotherapy and endovenous ablation have made these treatments more affordable and accessible, boosting market growth.

Restraints in the Global Varicose Veins Treatment Market

Regulatory Challenges

Regulatory requirements and product approval processes can pose challenges for manufacturers in the varicose veins treatment market. Obtaining regulatory approvals and complying with various regulations in different countries can be time-consuming and costly, affecting the introduction of new treatments and innovations.

Alternative Treatment Options

Alternative treatments, such as compression therapy and lifestyle modifications, may be considered by some patients as an initial or complementary approach to managing varicose veins. These non-invasive options can compete with more invasive treatment methods, potentially impacting the market growth of varicose veins treatments.

Market Trends of the Global Varicose Veins Treatment Key

Growing Emphasis on Combination Therapies

Combination therapies involving multiple treatment modalities are gaining popularity in varicose veins treatment. Combining procedures such as endovenous ablation and sclerotherapy can optimize outcomes by targeting different aspects of the venous disease, leading to improved efficacy and patient satisfaction.

Focus on Patient-Centric Approaches

There is an increasing emphasis on patient-centric care in varicose veins treatment. Healthcare providers are focusing on personalized treatment plans, patient education, and shared decision-making to ensure optimal outcomes and patient satisfaction.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Varicose Veins Treatment Market by Type
    • Market Overview
    • Endovenous Ablation
    • and Surgical Ligation & Stripping
  • Global Varicose Veins Treatment Market by End-use
    • Market Overview
    • Vein clinics
    • hospitals
    • and ambulatory care units
  • Global Varicose Veins Treatment Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AngioDynamics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lumenis (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Syneron Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Biolitec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BTG International Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vascular Solutions, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Energist Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eufoton (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Quanta System (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Miravas (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vein Clinics of America (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Alna-Medical System GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Miravas SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sciton, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LSO Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vascular Insights, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LSO Medical SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments